ArticleOncotarget2014

Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer.

Catherine Burkhart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.